Modification of amyloid-beta peptide aggregation via photoactivation of strained Ru( ii ) polypyridyl complexes
Alzheimer's disease (AD) is a chronic neurodegenerative disorder characterized by progressive and irreversible damage to the brain. One of the hallmarks of the disease is the presence of both soluble and insoluble aggregates of the amyloid beta (Aβ) peptide in the brain, and these aggregates ar...
Gespeichert in:
Veröffentlicht in: | Chemical science (Cambridge) 2021-04, Vol.12 (21), p.7510-7520 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 7520 |
---|---|
container_issue | 21 |
container_start_page | 7510 |
container_title | Chemical science (Cambridge) |
container_volume | 12 |
creator | Bataglioli, Janaina C. Gomes, Luiza M. F. Maunoir, Camille Smith, Jason R. Cole, Houston D. McCain, Julia Sainuddin, Tariq Cameron, Colin G. McFarland, Sherri A. Storr, Tim |
description | Alzheimer's disease (AD) is a chronic neurodegenerative disorder characterized by progressive and irreversible damage to the brain. One of the hallmarks of the disease is the presence of both soluble and insoluble aggregates of the amyloid beta (Aβ) peptide in the brain, and these aggregates are considered central to disease progression. Thus, the development of small molecules capable of modulating Aβ peptide aggregation may provide critical insight into the pathophysiology of AD. In this work we investigate how photoactivation of three distorted Ru(
ii
) polypyridyl complexes (
Ru1–3
) alters the aggregation profile of the Aβ peptide. Photoactivation of
Ru1–3
results in the loss of a 6,6′-dimethyl-2,2′-bipyridyl (6,6′-dmb) ligand, affording
cis
-exchangeable coordination sites for binding to the Aβ peptide. Both
Ru1
and
Ru2
contain an extended planar imidazo[4,5-
f
][1,10]phenanthroline ligand, as compared to a 2,2′-bipyridine ligand for
Ru3
, and we show that the presence of the phenanthroline ligand promotes covalent binding to Aβ peptide His residues, and in addition, leads to a pronounced effect on peptide aggregation immediately after photoactivation. Interestingly, all three complexes resulted in a similar aggregate size distribution at 24 h, forming insoluble amorphous aggregates as compared to significant fibril formation for peptide alone. Photoactivation of
Ru1–3
in the presence of pre-formed Aβ
1–42
fibrils results in a change to amorphous aggregate morphology, with
Ru1
and
Ru2
forming large amorphous aggregates immediately after activation. Our results show that photoactivation of
Ru1–3
in the presence of either monomeric or fibrillar Aβ
1–42
results in the formation of large amorphous aggregates as a common endpoint, with Ru complexes incorporating the extended phenanthroline ligand accelerating this process and thereby limiting the formation of oligomeric species in the initial stages of the aggregation process that are reported to show considerable toxicity. |
doi_str_mv | 10.1039/D1SC00004G |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8171320</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2535830547</sourcerecordid><originalsourceid>FETCH-LOGICAL-c313t-2fa0894b7adee3a970b3e909c3bb71a6fb4e26c98611f1e6f34ae83c86cd55b63</originalsourceid><addsrcrecordid>eNpVkU1Lw0AQhhdRbKm9-AsWvKgQ3c3k8yJI1SpUBD_Oy2Yzm25Js3GTFPPvTWmpOJcZZp5554Uh5JyzG84gvX3gHzM2RDA_ImOfBdyLQkiPD7XPRmTaNKstA8BDPz4lIwh4BEngj4l9tbnRRsnW2IpaTeW6L63JvQxbSWusW5MjlUXhsNgxGzP0l7a1UrVmc9hrWidNhTl97y6pMfSK1rbs696ZvC-psuu6xB9szsiJlmWD032ekK-nx8_Zs7d4m7_M7heeAg6t52vJkjTIYpkjgkxjlgGmLFWQZTGXkc4C9COVJhHnmmOkIZCYgEoilYdhFsGE3O106y5bY66wGvyVonZmLV0vrDTi_6QyS1HYjUh4zMFng8DFXsDZ7w6bVqxs56rBs_BDCBNgYRAP1PWOUs42jUN9uMCZ2P5H_P0HfgFtbINq</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2535830547</pqid></control><display><type>article</type><title>Modification of amyloid-beta peptide aggregation via photoactivation of strained Ru( ii ) polypyridyl complexes</title><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>PubMed Central Open Access</source><creator>Bataglioli, Janaina C. ; Gomes, Luiza M. F. ; Maunoir, Camille ; Smith, Jason R. ; Cole, Houston D. ; McCain, Julia ; Sainuddin, Tariq ; Cameron, Colin G. ; McFarland, Sherri A. ; Storr, Tim</creator><creatorcontrib>Bataglioli, Janaina C. ; Gomes, Luiza M. F. ; Maunoir, Camille ; Smith, Jason R. ; Cole, Houston D. ; McCain, Julia ; Sainuddin, Tariq ; Cameron, Colin G. ; McFarland, Sherri A. ; Storr, Tim</creatorcontrib><description>Alzheimer's disease (AD) is a chronic neurodegenerative disorder characterized by progressive and irreversible damage to the brain. One of the hallmarks of the disease is the presence of both soluble and insoluble aggregates of the amyloid beta (Aβ) peptide in the brain, and these aggregates are considered central to disease progression. Thus, the development of small molecules capable of modulating Aβ peptide aggregation may provide critical insight into the pathophysiology of AD. In this work we investigate how photoactivation of three distorted Ru(
ii
) polypyridyl complexes (
Ru1–3
) alters the aggregation profile of the Aβ peptide. Photoactivation of
Ru1–3
results in the loss of a 6,6′-dimethyl-2,2′-bipyridyl (6,6′-dmb) ligand, affording
cis
-exchangeable coordination sites for binding to the Aβ peptide. Both
Ru1
and
Ru2
contain an extended planar imidazo[4,5-
f
][1,10]phenanthroline ligand, as compared to a 2,2′-bipyridine ligand for
Ru3
, and we show that the presence of the phenanthroline ligand promotes covalent binding to Aβ peptide His residues, and in addition, leads to a pronounced effect on peptide aggregation immediately after photoactivation. Interestingly, all three complexes resulted in a similar aggregate size distribution at 24 h, forming insoluble amorphous aggregates as compared to significant fibril formation for peptide alone. Photoactivation of
Ru1–3
in the presence of pre-formed Aβ
1–42
fibrils results in a change to amorphous aggregate morphology, with
Ru1
and
Ru2
forming large amorphous aggregates immediately after activation. Our results show that photoactivation of
Ru1–3
in the presence of either monomeric or fibrillar Aβ
1–42
results in the formation of large amorphous aggregates as a common endpoint, with Ru complexes incorporating the extended phenanthroline ligand accelerating this process and thereby limiting the formation of oligomeric species in the initial stages of the aggregation process that are reported to show considerable toxicity.</description><identifier>ISSN: 2041-6520</identifier><identifier>EISSN: 2041-6539</identifier><identifier>DOI: 10.1039/D1SC00004G</identifier><identifier>PMID: 34163842</identifier><language>eng</language><publisher>Cambridge: Royal Society of Chemistry</publisher><subject>Agglomeration ; Aggregates ; Alzheimer's disease ; Binding ; Brain damage ; Chemistry ; Ligands ; Morphology ; Peptides ; Ruthenium compounds ; Size distribution ; Toxicity</subject><ispartof>Chemical science (Cambridge), 2021-04, Vol.12 (21), p.7510-7520</ispartof><rights>Copyright Royal Society of Chemistry 2021</rights><rights>This journal is © The Royal Society of Chemistry 2021 The Royal Society of Chemistry</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c313t-2fa0894b7adee3a970b3e909c3bb71a6fb4e26c98611f1e6f34ae83c86cd55b63</citedby><cites>FETCH-LOGICAL-c313t-2fa0894b7adee3a970b3e909c3bb71a6fb4e26c98611f1e6f34ae83c86cd55b63</cites><orcidid>0000-0001-7380-2192 ; 0000-0002-3163-6218 ; 0000-0002-8028-5055 ; 0000-0003-3368-2063</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8171320/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8171320/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,27901,27902,53766,53768</link.rule.ids></links><search><creatorcontrib>Bataglioli, Janaina C.</creatorcontrib><creatorcontrib>Gomes, Luiza M. F.</creatorcontrib><creatorcontrib>Maunoir, Camille</creatorcontrib><creatorcontrib>Smith, Jason R.</creatorcontrib><creatorcontrib>Cole, Houston D.</creatorcontrib><creatorcontrib>McCain, Julia</creatorcontrib><creatorcontrib>Sainuddin, Tariq</creatorcontrib><creatorcontrib>Cameron, Colin G.</creatorcontrib><creatorcontrib>McFarland, Sherri A.</creatorcontrib><creatorcontrib>Storr, Tim</creatorcontrib><title>Modification of amyloid-beta peptide aggregation via photoactivation of strained Ru( ii ) polypyridyl complexes</title><title>Chemical science (Cambridge)</title><description>Alzheimer's disease (AD) is a chronic neurodegenerative disorder characterized by progressive and irreversible damage to the brain. One of the hallmarks of the disease is the presence of both soluble and insoluble aggregates of the amyloid beta (Aβ) peptide in the brain, and these aggregates are considered central to disease progression. Thus, the development of small molecules capable of modulating Aβ peptide aggregation may provide critical insight into the pathophysiology of AD. In this work we investigate how photoactivation of three distorted Ru(
ii
) polypyridyl complexes (
Ru1–3
) alters the aggregation profile of the Aβ peptide. Photoactivation of
Ru1–3
results in the loss of a 6,6′-dimethyl-2,2′-bipyridyl (6,6′-dmb) ligand, affording
cis
-exchangeable coordination sites for binding to the Aβ peptide. Both
Ru1
and
Ru2
contain an extended planar imidazo[4,5-
f
][1,10]phenanthroline ligand, as compared to a 2,2′-bipyridine ligand for
Ru3
, and we show that the presence of the phenanthroline ligand promotes covalent binding to Aβ peptide His residues, and in addition, leads to a pronounced effect on peptide aggregation immediately after photoactivation. Interestingly, all three complexes resulted in a similar aggregate size distribution at 24 h, forming insoluble amorphous aggregates as compared to significant fibril formation for peptide alone. Photoactivation of
Ru1–3
in the presence of pre-formed Aβ
1–42
fibrils results in a change to amorphous aggregate morphology, with
Ru1
and
Ru2
forming large amorphous aggregates immediately after activation. Our results show that photoactivation of
Ru1–3
in the presence of either monomeric or fibrillar Aβ
1–42
results in the formation of large amorphous aggregates as a common endpoint, with Ru complexes incorporating the extended phenanthroline ligand accelerating this process and thereby limiting the formation of oligomeric species in the initial stages of the aggregation process that are reported to show considerable toxicity.</description><subject>Agglomeration</subject><subject>Aggregates</subject><subject>Alzheimer's disease</subject><subject>Binding</subject><subject>Brain damage</subject><subject>Chemistry</subject><subject>Ligands</subject><subject>Morphology</subject><subject>Peptides</subject><subject>Ruthenium compounds</subject><subject>Size distribution</subject><subject>Toxicity</subject><issn>2041-6520</issn><issn>2041-6539</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNpVkU1Lw0AQhhdRbKm9-AsWvKgQ3c3k8yJI1SpUBD_Oy2Yzm25Js3GTFPPvTWmpOJcZZp5554Uh5JyzG84gvX3gHzM2RDA_ImOfBdyLQkiPD7XPRmTaNKstA8BDPz4lIwh4BEngj4l9tbnRRsnW2IpaTeW6L63JvQxbSWusW5MjlUXhsNgxGzP0l7a1UrVmc9hrWidNhTl97y6pMfSK1rbs696ZvC-psuu6xB9szsiJlmWD032ekK-nx8_Zs7d4m7_M7heeAg6t52vJkjTIYpkjgkxjlgGmLFWQZTGXkc4C9COVJhHnmmOkIZCYgEoilYdhFsGE3O106y5bY66wGvyVonZmLV0vrDTi_6QyS1HYjUh4zMFng8DFXsDZ7w6bVqxs56rBs_BDCBNgYRAP1PWOUs42jUN9uMCZ2P5H_P0HfgFtbINq</recordid><startdate>20210424</startdate><enddate>20210424</enddate><creator>Bataglioli, Janaina C.</creator><creator>Gomes, Luiza M. F.</creator><creator>Maunoir, Camille</creator><creator>Smith, Jason R.</creator><creator>Cole, Houston D.</creator><creator>McCain, Julia</creator><creator>Sainuddin, Tariq</creator><creator>Cameron, Colin G.</creator><creator>McFarland, Sherri A.</creator><creator>Storr, Tim</creator><general>Royal Society of Chemistry</general><general>The Royal Society of Chemistry</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7SR</scope><scope>8BQ</scope><scope>8FD</scope><scope>JG9</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-7380-2192</orcidid><orcidid>https://orcid.org/0000-0002-3163-6218</orcidid><orcidid>https://orcid.org/0000-0002-8028-5055</orcidid><orcidid>https://orcid.org/0000-0003-3368-2063</orcidid></search><sort><creationdate>20210424</creationdate><title>Modification of amyloid-beta peptide aggregation via photoactivation of strained Ru( ii ) polypyridyl complexes</title><author>Bataglioli, Janaina C. ; Gomes, Luiza M. F. ; Maunoir, Camille ; Smith, Jason R. ; Cole, Houston D. ; McCain, Julia ; Sainuddin, Tariq ; Cameron, Colin G. ; McFarland, Sherri A. ; Storr, Tim</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c313t-2fa0894b7adee3a970b3e909c3bb71a6fb4e26c98611f1e6f34ae83c86cd55b63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Agglomeration</topic><topic>Aggregates</topic><topic>Alzheimer's disease</topic><topic>Binding</topic><topic>Brain damage</topic><topic>Chemistry</topic><topic>Ligands</topic><topic>Morphology</topic><topic>Peptides</topic><topic>Ruthenium compounds</topic><topic>Size distribution</topic><topic>Toxicity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bataglioli, Janaina C.</creatorcontrib><creatorcontrib>Gomes, Luiza M. F.</creatorcontrib><creatorcontrib>Maunoir, Camille</creatorcontrib><creatorcontrib>Smith, Jason R.</creatorcontrib><creatorcontrib>Cole, Houston D.</creatorcontrib><creatorcontrib>McCain, Julia</creatorcontrib><creatorcontrib>Sainuddin, Tariq</creatorcontrib><creatorcontrib>Cameron, Colin G.</creatorcontrib><creatorcontrib>McFarland, Sherri A.</creatorcontrib><creatorcontrib>Storr, Tim</creatorcontrib><collection>CrossRef</collection><collection>Engineered Materials Abstracts</collection><collection>METADEX</collection><collection>Technology Research Database</collection><collection>Materials Research Database</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Chemical science (Cambridge)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bataglioli, Janaina C.</au><au>Gomes, Luiza M. F.</au><au>Maunoir, Camille</au><au>Smith, Jason R.</au><au>Cole, Houston D.</au><au>McCain, Julia</au><au>Sainuddin, Tariq</au><au>Cameron, Colin G.</au><au>McFarland, Sherri A.</au><au>Storr, Tim</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Modification of amyloid-beta peptide aggregation via photoactivation of strained Ru( ii ) polypyridyl complexes</atitle><jtitle>Chemical science (Cambridge)</jtitle><date>2021-04-24</date><risdate>2021</risdate><volume>12</volume><issue>21</issue><spage>7510</spage><epage>7520</epage><pages>7510-7520</pages><issn>2041-6520</issn><eissn>2041-6539</eissn><abstract>Alzheimer's disease (AD) is a chronic neurodegenerative disorder characterized by progressive and irreversible damage to the brain. One of the hallmarks of the disease is the presence of both soluble and insoluble aggregates of the amyloid beta (Aβ) peptide in the brain, and these aggregates are considered central to disease progression. Thus, the development of small molecules capable of modulating Aβ peptide aggregation may provide critical insight into the pathophysiology of AD. In this work we investigate how photoactivation of three distorted Ru(
ii
) polypyridyl complexes (
Ru1–3
) alters the aggregation profile of the Aβ peptide. Photoactivation of
Ru1–3
results in the loss of a 6,6′-dimethyl-2,2′-bipyridyl (6,6′-dmb) ligand, affording
cis
-exchangeable coordination sites for binding to the Aβ peptide. Both
Ru1
and
Ru2
contain an extended planar imidazo[4,5-
f
][1,10]phenanthroline ligand, as compared to a 2,2′-bipyridine ligand for
Ru3
, and we show that the presence of the phenanthroline ligand promotes covalent binding to Aβ peptide His residues, and in addition, leads to a pronounced effect on peptide aggregation immediately after photoactivation. Interestingly, all three complexes resulted in a similar aggregate size distribution at 24 h, forming insoluble amorphous aggregates as compared to significant fibril formation for peptide alone. Photoactivation of
Ru1–3
in the presence of pre-formed Aβ
1–42
fibrils results in a change to amorphous aggregate morphology, with
Ru1
and
Ru2
forming large amorphous aggregates immediately after activation. Our results show that photoactivation of
Ru1–3
in the presence of either monomeric or fibrillar Aβ
1–42
results in the formation of large amorphous aggregates as a common endpoint, with Ru complexes incorporating the extended phenanthroline ligand accelerating this process and thereby limiting the formation of oligomeric species in the initial stages of the aggregation process that are reported to show considerable toxicity.</abstract><cop>Cambridge</cop><pub>Royal Society of Chemistry</pub><pmid>34163842</pmid><doi>10.1039/D1SC00004G</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0001-7380-2192</orcidid><orcidid>https://orcid.org/0000-0002-3163-6218</orcidid><orcidid>https://orcid.org/0000-0002-8028-5055</orcidid><orcidid>https://orcid.org/0000-0003-3368-2063</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2041-6520 |
ispartof | Chemical science (Cambridge), 2021-04, Vol.12 (21), p.7510-7520 |
issn | 2041-6520 2041-6539 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8171320 |
source | DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central; PubMed Central Open Access |
subjects | Agglomeration Aggregates Alzheimer's disease Binding Brain damage Chemistry Ligands Morphology Peptides Ruthenium compounds Size distribution Toxicity |
title | Modification of amyloid-beta peptide aggregation via photoactivation of strained Ru( ii ) polypyridyl complexes |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T00%3A03%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Modification%20of%20amyloid-beta%20peptide%20aggregation%20via%20photoactivation%20of%20strained%20Ru(%20ii%20)%20polypyridyl%20complexes&rft.jtitle=Chemical%20science%20(Cambridge)&rft.au=Bataglioli,%20Janaina%20C.&rft.date=2021-04-24&rft.volume=12&rft.issue=21&rft.spage=7510&rft.epage=7520&rft.pages=7510-7520&rft.issn=2041-6520&rft.eissn=2041-6539&rft_id=info:doi/10.1039/D1SC00004G&rft_dat=%3Cproquest_pubme%3E2535830547%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2535830547&rft_id=info:pmid/34163842&rfr_iscdi=true |